Correlation between the amount of follicle-stimulating hormone administered and plasma and follicular fluid vascular endothelial growth factor concentrations in women undergoing in vitro fertilization.
暂无分享,去创建一个
[1] R. Stouffer,et al. Vascular endothelial growth factor production by human luteinized granulosa cells in vitro. , 1997, Human reproduction.
[2] D. Seifer,et al. Follicular fluid vascular endothelial growth factor concentrations are elevated in women of advanced reproductive age undergoing ovulation induction. , 1997, Fertility and sterility.
[3] A. Ferrari,et al. Expression of vascular endothelial growth factor in human luteinizing granulosa cells and its correlation with the response to controlled ovarian hyperstimulation. , 1997, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[4] R. Stouffer,et al. Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization. , 1997, Fertility and sterility.
[5] R. Stouffer,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Follicle-Stimulating Hormone and Luteinizing Hormone/ Chorionic Gonadotropin Stimulation of Vascular Endothelial Growth Factor Production by Macaq , 2022 .
[6] S. Berga,et al. Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report. , 1996, Fertility and sterility.
[7] R. Edwards,et al. Principles and Practice of Assisted Human Reproduction , 1995 .
[8] M. Breckwoldt,et al. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. , 1995, The Journal of clinical endocrinology and metabolism.
[9] D. Connolly,et al. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome , 1994, The Lancet.
[10] G. Haines,et al. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. , 1994, Journal of immunology.
[11] M. Breckwoldt,et al. Vascular endothelial growth factor (VEGF) messenger ribonucleic acid (mRNA) expression in luteinized human granulosa cells in vitro. , 1993, The Journal of clinical endocrinology and metabolism.
[12] D. Charnock-Jones,et al. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. , 1993, Biology of reproduction.
[13] N. Ferrara,et al. Molecular and biological properties of the vascular endothelial growth factor family of proteins. , 1992, Endocrine reviews.
[14] I. Carlson,et al. Diagnosis-specific serum 17 beta-estradiol (E2) upper limits for treatment with menotropins using a 125I direct E2 assay. , 1984, Fertility and sterility.
[15] P. Fishman,et al. Interleukin-2 and ovarian hyperstimulation syndrome: a pilot study. , 1995, Human reproduction.
[16] E. Manseau,et al. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. , 1995, American Journal of Pathology.
[17] H. Dvorak,et al. Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells. , 1991, The American journal of pathology.